Skin Manifestations of Internal Disease Part 2 Erythroderma Table 54-2 Erythroderma is the term used when the majority of the skin surface is erythematous red in color.. The major et
Trang 1Chapter 054 Skin Manifestations
of Internal Disease
(Part 2)
Erythroderma
(Table 54-2) Erythroderma is the term used when the majority of the skin
surface is erythematous (red in color) There may be associated scale, erosions, or pustules as well as shedding of the hair and nails Potential systemic manifestations include fever, chills, hypothermia, reactive lymphadenopathy, peripheral edema, hypoalbuminemia, and high-output cardiac failure The major etiologies of erythroderma are (1) cutaneous diseases such as psoriasis and dermatitis (Table 54-3); (2) drugs; (3) systemic diseases, most commonly CTCL; and (4) idiopathic In the first three groups, the location and description of the initial lesions, prior to the development of the erythroderma, aid in the diagnosis For example, a history of red scaly plaques on the elbows and knees would point
Trang 2to psoriasis It is also important to examine the skin carefully for a migration of the erythema and associated secondary changes such as pustules or erosions Migratory waves of erythema studded with superficial pustules are seen in
pustular psoriasis
Table 54-2 Causes of Erythroderma
1 Primary cutaneous disorders
a Psoriasisa
b Dermatitis [atopic, contact >> seborrheic or stasis (with autosensitization)]a
c Pityriasis rubra pilaris
2 Drugs
Trang 33 Systemic diseases
a Cutaneous T cell lymphoma
b Lymphoma
4 Idiopathic
a
Discussed in detail in Chap 53
Table 54-3 Erythroderma (Primary Cutaneous Disorders)
Initial Lesions
Locati
on of Initial Lesions
Othe
r Findings
Diag nostic Aids
Treat ment
Psori
asisa
Pink-red, silvery scale, sharply demarcated
Elbow
s, knees, scalp,
presacral area
Nail dystrophy, arthritis, pustules
Skin biopsy
Topic
al glucocortico ids, vitamin
Trang 4retinoid and/or PUVA; MTX, cyclosporine , anti-TNF agents
Derm
atitisa
Atop
ic
Acute:
Erythe
ma, fine scale, crust, indistinct borders
Antec ubital and popliteal fossae, neck, hands
Prurit
us
Fami
ly history of atopy, including
Skin biopsy
Topic
al glucocortico ids,
tacrolimus, pimecrolimu
s, tar, and
Trang 5Chronic:
Lichenif
ication
(increased skin
markings)
asthma, allergic rhinitis or conjunctiviti
s, and atopic dermatitis
Excl ude
secondary infection
aureus
Excl ude
superimpose
d irritant or allergic contact dermatitis
antipruritics; oral
antihistamin es; open wet dressings;
UV-A; PUVA; oral/IM glucocortico ids; MTX; cyclosporine
Topic
al or oral antibiotics
Trang 6Cont
act
Local:
Erythe
ma, crusting, vesicles, and bullae
Depen
offending agent
Irrita nt—onset often within hours
Aller gic—
delayed-type hypersensiti vity; lag time of 48 h
Patch testing
Remo
ve irritant or allergen; topical glucocortico ids; oral antihistamin es; oral/IM glucocortico ids
Systemic :
Erythe
ma, fine scale, crust
Gener alized
Patie
history of allergic contact dermatitis to topical agent and
Patch testing
Same
as local
Trang 7then receives systemic medication
structurally related, e.g., ethylenedia mine (topical), aminophylli
ne (IV)
Sebo
rrheic (rare)
Pink-red, greasy scale
Scalp, nasolabial folds, eyebrows, intertriginous zones
Flare
stress, HIV infection
Asso ciated with Parkinson's
Skin biopsy
Topic
al glucocortico
imidazoles
Trang 8disease
Stasis
(with
autosensitiza
tion)
Erythem
a, crusting, excoriations
Lower extremities
Prurit
us, lower extremity edema
Histo
ry of venous ulcers, thrombophl ebitis, and/or cellulitis
Excl ude
cellulitis
Excl ude
superimpose
d contact
Skin biopsy
Topic
al glucocortico ids; open wet
dressings; leg
elevation; pressure stockings
Trang 9dermatitis, e.g., topical neomycin
Pityri
asis rubra
pilaris
Orange-red,
perifollicular papules
Gener alized, but characteristic
"skip" areas
of normal skin
Wax-like
keratoderma
Excl ude
cutaneous T cell
lymphoma
Skin biopsy
Isotre tinoin or acitretin; methotrexate
a
Discussed in detail in Chap 53
Note: PUVA, psoralens + ultraviolet A irradiation; UV-B, ultraviolet B;
UV-A, ultraviolet A; MTX, methotrexate; TNF, tumor necrosis factor